Work

Milatuzumab: a promising new agent for the treatment of lymphoid malignancies

Year: 2008

Type: review

Source: Expert Opinion on Investigational Drugs

DOI: 10.1517/13543780802636162

Authors: Tomer Mark, Peter Martin, John P Leonard, Ruben Niesvizky

Institutions: NewYork–Presbyterian Hospital, Cornell University, Weill Cornell Medical Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2004362201

FWCI: 0.157

Cites: 44

Cited by: 26

Related to: 10